Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The net-zero target approval complements the company's near-term emission reduction targets
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Developed in consultation with clinicians and patients for an enhanced user experience
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
At 24 months, data from the Phase 1 exPDite trial continue to show a favorable safety profile in all 12 participants in the trial’s high and low dose cohorts
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
Subscribe To Our Newsletter & Stay Updated
